My Lords, because of my interests as a veterinarian and as declared in the register, I shall confine my remarks to the impact of the Bill on animals, particularly in terms of disease resistance, the environment and animal welfare. These are overlapping issues for which, in my opinion, there is huge potential for positive effects with the adoption of new breeding technologies.
Notable recent advances in molecular biology relevant to the Bill include the increased speed and lower cost of whole-genome sequencing, as well as the precise manipulation of the genome by such means as gene editing. Against this background of scientific advances, although it has long been known that there is variation within and between species of animals in susceptibility to infectious pathogens, this has, by and large, not been exploited and emphasised in the conventional breeding of animals; conventional selective breeding has tended to concentrate on other productivity traits.
Now, with whole-genome sequencing, gene editing and using the range of genetic resources represented by a variety of breeds of livestock—rare breeds are a particularly valuable resource here—there is now a real opportunity to select for disease resistance relatively rapidly and very precisely. For example, using gene-editing technology, pigs have been bred with resistance to porcine reproductive and respiratory syndrome, a viral infectious disease of global importance that causes extremely high morbidity and mortality. In Europe alone, it is estimated to cost more than £1.3 billion per year.
With regard to avian flu, with which we are all now familiar and which is currently causing huge mortality in both wild birds and domestic poultry throughout Europe, it has been possible to gene-edit chicken cells
in culture to make them resistant to the avian flu virus. This gives hope that poultry with genetic resistance to this pathogen could be developed.
With regard to environmental issues, by reducing disease morbidity and mortality, new breeding technologies have the potential not only to improve food security but to maintain output with fewer animals and reduced land use, while at the same time reducing drug and chemical usage—notably that of antibiotics and parasiticides—to help combat the global problems of antimicrobial resistance and environmental pollution.
A further major environmental benefit is the reduction of greenhouse gas emissions from both reducing morbidity and mortality—that is a major cause of emissions that do not lead to any productive benefit—and directly breeding animals, particularly cattle, with reduced methane emissions. We know that that is a heritable trait in cows. So, I would argue that, in total, there are some substantial potential environmental gains.
With regard to welfare—let us remember that disease is a major welfare issue—reducing disease is a huge welfare gain, as I have outlined. In addition, welfare could potentially be improved by reducing the need for certain potentially painful management procedures, such as disbudding calves so that they do not grow horns or breeding polled cattle. Sex determination could avoid the large-scale culling of, for example, male chicks from layer flocks of chickens.
Concerns about animal welfare, as we have already heard, are raised; they are sincerely held but I am yet to be convinced that they are well founded in that they seem not to be specific in any way to precision breeding or gene editing, which experts in the subject maintain mimic natural mutational processes and conventional breeding. As with the introduction of any new technology, it is important to weigh the benefit-cost ratio. In my opinion, in this case, it is very positive in favour of the technology—provided, of course, that there are appropriate regulations and safeguards.
Turning to that issue, the Bill sets out a number of requirements, which the Minister elucidated, that must be met to enable precision-bred animals to be developed and marketed. These measures are in addition to existing animal welfare legislation. I will illustrate that in a bit of detail, if I may.
This Bill does not change existing legislation safeguarding, for example, animals in research and development. They are protected by the Animal (Scientific Procedures) Act 1986, world-class legislation which protects animals during the research and development of drugs and vaccines for humans and for animals. Also, the Bill does not change the Animal Welfare Act 2006, which protects animals in many other ways. I highlight two aspects of the Animal Welfare Act and subsequent regulations. The Welfare of Farmed Animals (England) Regulations 2007 state:
“Natural or artificial breeding or breeding procedures which cause, or are likely to cause, suffering or injury to any of the animals concerned, must not be practised ... Animals may only be kept for farming purposes if it can reasonably be expected, on the basis of their genotype or phenotype, that they can be kept without any detrimental effect on their health or welfare.”
Regarding dogs, which my noble friend Lord Krebs mentioned, the Animal Welfare (Licensing of Activities Involving Animals) (England) Regulations 2018 state:
“No dog may be kept for breeding if it can reasonably be expected, on the basis of its genotype, phenotype or state of health that breeding from it could have a detrimental effect on its health or welfare or the health or welfare of its offspring.”
I suggest that these two pieces of legislation are relevant to this Bill.
Moreover, it is generally agreed that, where possible, welfare assessments should look at the outcomes of any given management or breeding procedure and should not, without evidence, presume certain systems are good or bad for welfare a priori. I am ashamed to say that current natural breeding and management practices can lead, and have historically led, to welfare issues. I cite double-muscled Belgian Blue cattle breeds, which initially had to be delivered by caesarean section, and brachycephalic—or short-nosed—dogs, which we have bred with increasing levels of deformity as a fashionable trade, but which suffer all their lives from chronic ill health.
This Bill introduces additional animal welfare monitoring and checks over and above existing animal welfare legislation. One might argue that if existing legislation was fully enforced, the sincerely held concerns about negative welfare outcomes of this Bill could be assuaged.
The Government have said that the application of this Bill to animals will not take place until a regulatory regime is in place. Is this regulatory regime what is currently outlined in the Bill, or does it refer to additional regulatory measures that might be brought in?
Finally, I have some concerns which I share with others about gene drive technology. Would gene drive technology implemented by gene editing be permitted under this Bill, or will gene drive be classed as GMO and subject to existing GMO regulations? Gene drive technology is being researched not only for use in insects in the tropics to prevent the transmission of disease but in mammals, for example, for the potential population control of alien species such as grey squirrels. It involves the release into the environment of gene-edited individuals, characteristics of which, such as producing male-only offspring, are naturally amplified through the wild population. This is essentially an irreversible process which, if applied to wild animals, has considerable consequences for biodiversity and the environment, and has international ramifications too. Will gene drive technology, achieved by gene editing, be permitted under the Bill? I will fully understand if the Minister wants to respond by letter.
In general, I support this Bill very strongly. It would allow exciting new technologies which have the potential to be a game-changer in how we control disease in animals, to improve animal welfare and to be beneficial to the environment.
5.54 pm